SMTL ID : 7r1a.1

Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-mer

Ligands

3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: N.359, Q.608, L.610 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 3 residues within 4Å: Chain E: N.359, Q.608, L.610 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 3 residues within 4Å: Chain F: N.359, Q.608, L.610 No protein-ligand interaction detected (PLIP)

48 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 3 residues within 4Å: Chain A: N.151, T.153, V.156 Ligand excluded by PLIP NAG.5: 3 residues within 4Å: Chain A: E.161, N.192, N.193 Ligand excluded by PLIP NAG.6: 2 residues within 4Å: Chain A: N.308, N.310 Ligand excluded by PLIP NAG.7: 2 residues within 4Å: Chain A: N.631, T.632 Ligand excluded by PLIP NAG.8: 1 residues within 4Å: Chain A: N.644 Ligand excluded by PLIP NAG.9: 1 residues within 4Å: Chain A: N.737 Ligand excluded by PLIP NAG.10: 1 residues within 4Å: Chain A: N.745 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain A: N.829, S.831 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain A: N.1126, T.1128, H.1129 Ligand excluded by PLIP NAG.13: 1 residues within 4Å: Chain A: N.1162 Ligand excluded by PLIP NAG.15: 2 residues within 4Å: Chain B: N.55, Q.342 Ligand excluded by PLIP NAG.16: 1 residues within 4Å: Chain B: N.92 Ligand excluded by PLIP NAG.17: 3 residues within 4Å: Chain B: V.318, N.324, Q.327 Ligand excluded by PLIP NAG.18: 2 residues within 4Å: Chain B: F.287, N.434 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain B: K.418, S.547, N.548 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain B: Q.83, N.105, N.196 Ligand excluded by PLIP NAG.22: 2 residues within 4Å: Chain C: N.55, Q.342 Ligand excluded by PLIP NAG.23: 1 residues within 4Å: Chain C: N.92 Ligand excluded by PLIP NAG.24: 3 residues within 4Å: Chain C: V.318, N.324, Q.327 Ligand excluded by PLIP NAG.25: 2 residues within 4Å: Chain C: F.287, N.434 Ligand excluded by PLIP NAG.26: 3 residues within 4Å: Chain C: K.418, S.547, N.548 Ligand excluded by PLIP NAG.27: 3 residues within 4Å: Chain C: Q.83, N.105, N.196 Ligand excluded by PLIP NAG.29: 2 residues within 4Å: Chain D: N.55, Q.342 Ligand excluded by PLIP NAG.30: 1 residues within 4Å: Chain D: N.92 Ligand excluded by PLIP NAG.31: 3 residues within 4Å: Chain D: V.318, N.324, Q.327 Ligand excluded by PLIP NAG.32: 2 residues within 4Å: Chain D: F.287, N.434 Ligand excluded by PLIP NAG.33: 3 residues within 4Å: Chain D: K.418, S.547, N.548 Ligand excluded by PLIP NAG.34: 3 residues within 4Å: Chain D: Q.83, N.105, N.196 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain E: N.151, T.153, V.156 Ligand excluded by PLIP NAG.36: 3 residues within 4Å: Chain E: E.161, N.192, N.193 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain E: N.308, N.310 Ligand excluded by PLIP NAG.38: 2 residues within 4Å: Chain E: N.631, T.632 Ligand excluded by PLIP NAG.39: 1 residues within 4Å: Chain E: N.644 Ligand excluded by PLIP NAG.40: 1 residues within 4Å: Chain E: N.737 Ligand excluded by PLIP NAG.41: 1 residues within 4Å: Chain E: N.745 Ligand excluded by PLIP NAG.42: 2 residues within 4Å: Chain E: N.829, S.831 Ligand excluded by PLIP NAG.43: 3 residues within 4Å: Chain E: N.1126, T.1128, H.1129 Ligand excluded by PLIP NAG.44: 1 residues within 4Å: Chain E: N.1162 Ligand excluded by PLIP NAG.45: 3 residues within 4Å: Chain F: N.151, T.153, V.156 Ligand excluded by PLIP NAG.46: 3 residues within 4Å: Chain F: E.161, N.192, N.193 Ligand excluded by PLIP NAG.47: 2 residues within 4Å: Chain F: N.308, N.310 Ligand excluded by PLIP NAG.48: 2 residues within 4Å: Chain F: N.631, T.632 Ligand excluded by PLIP NAG.49: 1 residues within 4Å: Chain F: N.644 Ligand excluded by PLIP NAG.50: 1 residues within 4Å: Chain F: N.737 Ligand excluded by PLIP NAG.51: 1 residues within 4Å: Chain F: N.745 Ligand excluded by PLIP NAG.52: 2 residues within 4Å: Chain F: N.829, S.831 Ligand excluded by PLIP NAG.53: 3 residues within 4Å: Chain F: N.1126, T.1128, H.1129 Ligand excluded by PLIP NAG.54: 1 residues within 4Å: Chain F: N.1162 Ligand excluded by PLIP

3 x ZN: ZINC ION(Non-covalent)

ZN.14: 3 residues within 4Å: Chain B: H.376, H.380, E.404 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:H.376, B:H.380, B:E.404, B:E.404 ZN.21: 3 residues within 4Å: Chain C: H.376, H.380, E.404 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:H.376, C:H.380, C:E.404, C:E.404 ZN.28: 3 residues within 4Å: Chain D: H.376, H.380, E.404 4 PLIP interactions: 4 interactions with chain D Metal complexes: D:H.376, D:H.380, D:E.404, D:E.404

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wrobel, A.G. et al., Evolution of the SARS-CoV-2 spike protein in the human host. Nat Commun (2022)

Release Date

2022-03-02

Peptides

Spike glycoprotein: AEF
Angiotensin-converting enzyme 2: BCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E
B

F
C

B
D

C
E

D
F

Spike glycoprotein

Angiotensin-converting enzyme 2

Related Entries With Identical Sequence